| Anthony L Nicotera, MD | |
|
1 Guthrie Sq, Sayre, PA 18840-1625 | |
| (570) 888-6666 | |
| (570) 882-4379 |
| Full Name | Anthony L Nicotera |
|---|---|
| Gender | Male |
| Speciality | Psychiatry & Neurology - Psychiatry |
| Location | 1 Guthrie Sq, Sayre, Pennsylvania |
| Accepts Medicare Assignments | Does not participate in Medicare Program. He may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1558344150 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | MD009797E (Pennsylvania) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Anthony L Nicotera, MD 1 Guthrie Sq, Sayre, PA 18840-1625 Ph: (570) 888-6666 | Anthony L Nicotera, MD 1 Guthrie Sq, Sayre, PA 18840-1625 Ph: (570) 888-6666 |
News Archive
The FDA announced a Consent Decree of permanent injunction filed March 2, 2009, enjoining KV Pharmaceutical Company, its subsidiaries ETHEX Corporation and Ther-Rx Corporation, and its principal officers from making and distributing adulterated and unapproved drugs.
LiveProcess Corporation, the market leader in web-based emergency preparedness and incident management solutions for hospitals and healthcare organizations, announced today that the U.S. Patent Office (PTO) has issued U.S. Patent No. 7,596,608 to LiveProcess.
Researchers from Japan's RIKEN SNP Research Center, collaborating with a team at the University of California, San Diego (UCSD), have discovered a new genetic variation that affects a child's risk of getting Kawasaki disease (KD), an illness characterized by acute inflammation of the arteries throughout the body.
Today, 13 year-old Children's Miracle Network Ambassador Mackenzie Scott announced the second annual Fire Truck O'Toys charity toy drive sponsored by Boxing Clever, Children's Miracle Network, The St. Louis Rams and Build-A-Bear Workshop.
Neoadjuvant, or pre-surgical, combination treatment with the immune checkpoint inhibitors tremelimumab (anti-CTLA-4) and durvalumab (anti-PD-1) was well-tolerated and showed early signs of activity in certain patients with localized bladder cancer who do not have standard treatment options available, according to a Phase I clinical trial conducted by The University of Texas MD Anderson Cancer Center.
› Verified 4 days ago
Mr. Richard John Flynn, MD Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 Fax: 570-882-3023 | |
Carlos Ynigo Dy Lopez, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-887-2838 Fax: 570-887-3192 | |
Charles R Mcgurk, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-6666 Fax: 570-882-4379 | |
Dr. Paul Edward Buckthal, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 | |
Dr. Han Suk Koh, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-5858 | |
Monique Elise Simpson, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 1 Guthrie Sq, Sayre, PA 18840 Phone: 570-888-6666 |